Lyme2miami Limited - Accounts to registrar (filleted) - small 18.2
Lyme2miami Limited - Accounts to registrar (filleted) - small 18.2
REGISTERED NUMBER: |
Unaudited Financial Statements |
for the Period 1 January 2021 to 31 March 2022 |
for |
Lyme2miami Limited |
Lyme2miami Limited (Registered number: 11355374) |
Contents of the Financial Statements |
for the Period 1 January 2021 to 31 March 2022 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 3 |
Lyme2miami Limited |
Company Information |
for the Period 1 January 2021 to 31 March 2022 |
DIRECTOR: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Level 7, Tower 12, |
18-22 Bridge Street, |
Spinningfields, |
Manchester |
M3 3BZ |
Lyme2miami Limited (Registered number: 11355374) |
Balance Sheet |
31 March 2022 |
31.3.22 | 31.12.20 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Investments | 4 |
CURRENT ASSETS |
Cash at bank |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital |
Retained earnings |
SHAREHOLDERS' FUNDS |
The director acknowledges his responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements were approved by the director and authorised for issue on |
Lyme2miami Limited (Registered number: 11355374) |
Notes to the Financial Statements |
for the Period 1 January 2021 to 31 March 2022 |
1. | STATUTORY INFORMATION |
Lyme2miami Limited is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Investments in subsidiaries |
Investments in subsidiary undertakings are recognised at cost. |
Taxation |
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the period was NIL (2020 - NIL). |
4. | FIXED ASSET INVESTMENTS |
31.3.22 | 31.12.20 |
£ | £ |
Shares in group undertakings |
Loans to group undertakings |
Other loans |
Lyme2miami Limited (Registered number: 11355374) |
Notes to the Financial Statements - continued |
for the Period 1 January 2021 to 31 March 2022 |
4. | FIXED ASSET INVESTMENTS - continued |
Additional information is as follows: |
Shares in |
group |
undertakings |
£ |
COST |
At 1 January 2021 |
Disposals | ( |
) |
At 31 March 2022 |
NET BOOK VALUE |
At 31 March 2022 |
At 31 December 2020 |
Loans to |
group | Other |
undertakings | loans | Totals |
£ | £ | £ |
At 1 January 2021 |
New in year |
Repayment in year | ( |
) | ( |
) |
At 31 March 2022 |
At 31 March 2022 the company owned 100% of the share capital in Lyme2miami Inc. |